References
- Bahr JL, Tour JM. 2002. Covalent chemistry of single-wall carbon nanotubes. J Mater Chem. 12:1952–1958.
- Banerjee S, Hemraj-Benny T, Wong SS. 2005. Covalent surface chemistry of single-walled carbon nanotubes. Adv. Mater. 17:17–29.
- Bhirde AA, Patel V, Gavard J, Zhang JF, Sousa AA, Masedunskas A, et al. 2009. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano. 3:307–316.
- Bianco A, Kostarelos K, Partidos CD, Prato M. 2005. Biomedical applications of functionalized carbon nanotubes. Chem Commun. 5:571–577.
- Britz DA, Khlobystov AN. 2006. Noncovalent interactions of molecules with single walled carbon nanotubes. Chem Soc Rev. 35:637–659.
- Chen R, Zhang Y, Wang D, Dai H. 2001. Non-covalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc. 123:3838–3839.
- Chen J, Hammon MA, Hu H, Chen YS, Rao AM, Eklund PC, Haddon RC. 1998. Solution properties of single walled carbon nanotubes. Science. 282:95–98.
- Cherukuri P, Bachilo SM, Litovsky SH, Weisman RB. 2004. Near- infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc. 126:15638–15639.
- Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nat Biotechnol. 21:1166–1170.
- Dai H. 2002. Carbon nanotubes: opportunities and challenges. Surf Sci. 500:218–241.
- Firme CP, Bandaru PR. 2010. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine. 6:245–256.
- Fraczek A, Menaszek E, Paluszkiewicz C, Blazewicz M. 2008. Comparative in vivo biocompatibility study of single-and multi-wall carbon nanotubes. Acta Biomater. 4:1593–1602.
- Grecory RE, Anne FD. 1993. Paclitaxel: A new antineoplastic agent for refractory ovarian cancer. Clin Pharm. 12:401–415.
- Hirsch A. 2002. Functionalization of single-walled carbon nanotubes. Angew Chem Int Ed Engl. 41:1853–1859.
- Kam NWS, O’Connell M, Wisdom JA, Dai H. 2005a. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A. 102:11600–11605.
- Kam NWS, Liu Z, Dai H. 2005b. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc. 127: 12492–12493.
- Lehn JM. 1985. Supramolecular chemistry: receptors, catalysts, and carriers. Science. 227:849–856.
- Liu Z, Cai WB, He LN, Nakayama N, Chen K, Sun XM, et al. 2007a. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol. 2:47–52.
- Liu Z, Winters M, Holodniy M, Dai HJ. 2007b. siRNA delivery into human T cells and primary cells with carbonnanotube transporters. Angew Chem Int Ed Engl. 46:2023–2027.
- Liu Z, Sun X, Nakayama-Ratchford N, Dai HJ. 2007c. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 1:50–56.
- Liu Z, Tabakman S, Welsher K, Dai H. 2009. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res. 2:85–120.
- Li RB, Wu R, Zhao L, Wu MH, Yang L, Zou HF. 2010. P-Glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nono. 4:1399–1408.
- Nakamura J, Nakajima N, Matsumura K, Hyon SH. 2011. In Vivo cancer targeting of water-soluble taxol by folic acid immobilization. J Nanotechnol. 2:106–112.
- Nicolaou KC, Riemer C, Kerr MA, Rideout D, Wrasidlo W. 1993. Design, synthesis and biological activity of protaxols. Nature. 364:464–466.
- O’Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS, Haroz EH, et al. 2002. Band gap fluorescence from individual single-walled carbon nanotubes. Science. 297:593–596.
- Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, et al. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 3:423–428.
- Prato M, Kostarelos K, Bianco A. 2008. Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res. 47:60–68.
- Shvedova A, Castranova V, Kisin E, Schwegler-Berry D, Murray A, Gandelsman V, et al. 2003. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health Part A. 66:1909–1926.
- Smart SK, Cassady AI, Lu GQ, Martin DJ. 2006. The biocompatibility of carbon nanotubes. Carbon. 44:1034–1047.
- Sun YP, Fu KF, Lin Y, Huang WJ. 2002. Functionalized carbon nanotubes: Properties and applications. Acc Chem Res. 35:1096–1104.
- Thierry B, Kujawa P, Tkaczyk C, Winnik FM, Bilodeau L, Tabrizian M. 2005. Delivery platform for hydrophobic drugs: prodrug approach combined with self-assembled multilayers. J Am Chem Soc. 127:1626–1627.
- Tian ZH, Shi Y, Yin M, Shen H, Jia NQ. 2011. Functionalized multiwalled carbon nanotubes-anticancer drug carriers: synthesis, targeting ability and antitumor activity. Nano Biomed Eng. 3: 157–162.
- You J, Li X, Cui FD, Du YZ, Yuan H, Hu FQ. 2008. Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology. 19:045102.
- Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 77:117–125.